查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390864

製剂开发外包市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Formulation Development Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球製剂开发外包市场规模达226亿美元。展望未来， IMARC Group预计到2028年市场规模将达到337亿美元，2022-2028年复合年增长率（CAGR）为6.89%。

製剂开发是指确定药品的专利性、生命週期和成功的过程。它还涉及预配製，包括分析测定开发和表征、用于稳定或增强产品溶解度的赋形剂筛选以及剂型开发。由于时间压力和缺乏内部资源，它经常被外包。配方开发外包还提供了许多好处，例如压缩时间、获取专业知识以及针对产品故障提供额外的保险。

製剂开发外包市场趋势：

糖尿病、慢性阻塞性肺病 (COPD)、癌症、气喘、关节炎和阿兹海默症等慢性病的盛行率不断上升，刺激了对新药发现和开发的需求。反过来，这也是导致製剂开发服务外包给世界各地的合约研究组织 (CRO) 的关键因素之一。除此之外，克服风险并节省药物通过开发管道的时间和金钱的需求也在增加。因此，全球领先的製药和生物技术公司正在药物开发过程的早期阶段与外包服务合作。再加上由于主要药物专利到期时间的增加，对创新药物的需求显着增加，正在推动市场成长。此外，一些国家的企业和管理机构扩大医疗保健支出正在创造有利的市场前景。此外，冠状病毒病（COVID-19）的爆发对临床试验的需求产生了积极影响，以找到针对传染性感染的有效治疗方法。这导致了对研发（R＆D）的广泛投资，以开发治疗方法，预计这将推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球製剂开发外包市场的表现如何，未来几年又将如何表现？
  • COVID-19 对全球製剂开发外包市场有何影响？
  • 主要区域市场有哪些？
  • 基于服务的市场区隔是什么？
  • 根据剂型，市场的细分情况如何？
  • 基于应用程式的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球製剂开发外包市场的架构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球製剂开发外包市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按服务分類的市场区隔

  • 製剂前服务
    • 市场走向
    • 关键环节
      • 发现和临床前服务
      • 分析服务
    • 市场预测
  • 配方优化
    • 市场走向
    • 关键环节
      • 第一阶段
      • 第二阶段
      • 第三阶段
      • 第四阶段
    • 市场预测

第 7 章：按剂型分類的市场细分

  • 可注射
    • 市场走向
    • 市场预测
  • 口服
    • 市场走向
    • 市场预测
  • 专题
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场区隔

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 遗传性疾病
    • 市场走向
    • 市场预测
  • 神经病学
    • 市场走向
    • 市场预测
  • 传染性疾病
    • 市场走向
    • 市场预测
  • 呼吸系统
    • 市场走向
    • 市场预测
  • 心血管
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 製药和生物製药公司
    • 市场走向
    • 市场预测
  • 政府和学术机构
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aizant Drug Research Solutions Private Limited
    • Catalent Inc.
    • Charles River Laboratories
    • Dr. Reddy's Laboratories Ltd.
    • Emergent BioSolutions Inc.
    • Intertek Group plc
    • Irisys LLC (Recro Pharma)
    • Laboratory Corporation of America Holdings
    • Lonza Group AG
    • Piramal Pharma Solutions
    • Quotient Sciences
    • Syngene International Limited (Biocon Limited)
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A4747

Abstract

The global formulation development outsourcing market size reached US$ 22.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.89% during 2022-2028.

Formulation development refers to the process of determining patentability, lifecycle, and the success of the pharmaceutical product. It also involves pre-formulation, including analytical assay development and characterization, excipient screening to stabilize or enhance the solubility of the product and dosage form development. It is often outsourced due to time pressure and a lack of internal resources. Formulation development outsourcing also offers numerous benefits, such as compressing timelines, accessing expertise, and providing extra insurance against product failure.

Formulation Development Outsourcing Market Trends:

The growing prevalence of chronic diseases, such as diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer's disease, is catalyzing the demand for the discovery and development of new drugs. This, in turn, represents one of the key factors resulting in the formulation development services being outsourced to contract research organizations (CROs) around the world. Besides this, there is a rise in the need to overcome the risk and save time and money involved in passing the drug through the development pipeline. As a result, leading pharmaceutical and biotechnological companies worldwide are partnering with outsourcing services in the early phases of the drug development process. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. Furthermore, expanding healthcare expenditure by business enterprises and governing agencies of several countries is creating a favorable market outlook. Moreover, the coronavirus disease (COVID-19) outbreak has positively influenced the need for clinical trials to find an effective treatment against the contagious infection. This has resulted in extensive investments in research and development (R&D) to develop therapeutics, which is projected to drive the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global formulation development outsourcing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on service, dosage form, application and end user.

Breakup by Service:

Pre-formulation Services

Discovery and Preclinical Services

Analytical Services

Formulation Optimization

Phase I

Phase II

Phase III

Phase IV

Breakup by Dosage Form:

Injectable

Oral

Topical

Others

Breakup by Application:

Oncology

Genetic Disorders

Neurology

Infectious Diseases

Respiratory

Cardiovascular

Others

Breakup by End User:

Pharmaceutical and Biopharmaceutical Companies

Government and Academic Institutes

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aizant Drug Research Solutions Private Limited, Catalent Inc., Charles River Laboratories, Dr. Reddy's Laboratories Ltd., Emergent BioSolutions Inc., Intertek Group plc, Irisys LLC (Recro Pharma), Laboratory Corporation of America Holdings, Lonza Group AG, Piramal Pharma Solutions, Quotient Sciences, Syngene International Limited (Biocon Limited) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global formulation development outsourcing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global formulation development outsourcing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the service?
  • What is the breakup of the market based on the dosage form?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global formulation development outsourcing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Formulation Development Outsourcing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Service

  • 6.1 Pre-formulation Services
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Discovery and Preclinical Services
      • 6.1.2.2 Analytical Services
    • 6.1.3 Market Forecast
  • 6.2 Formulation Optimization
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Phase I
      • 6.2.2.2 Phase II
      • 6.2.2.3 Phase III
      • 6.2.2.4 Phase IV
    • 6.2.3 Market Forecast

7 Market Breakup by Dosage Form

  • 7.1 Injectable
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Topical
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Oncology
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disorders
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Neurology
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Infectious Diseases
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Respiratory
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Cardiovascular
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biopharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Government and Academic Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aizant Drug Research Solutions Private Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Catalent Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Charles River Laboratories
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Dr. Reddy's Laboratories Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Emergent BioSolutions Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Intertek Group plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Irisys LLC (Recro Pharma)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Laboratory Corporation of America Holdings
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Piramal Pharma Solutions
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Quotient Sciences
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Syngene International Limited (Biocon Limited)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13 Thermo Fisher Scientific Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Formulation Development Outsourcing Market: Major Drivers and Challenges
  • Figure 2: Global: Formulation Development Outsourcing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Formulation Development Outsourcing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Formulation Development Outsourcing Market: Breakup by Service (in %), 2022
  • Figure 5: Global: Formulation Development Outsourcing Market: Breakup by Dosage Form (in %), 2022
  • Figure 6: Global: Formulation Development Outsourcing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Formulation Development Outsourcing Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Formulation Development Outsourcing Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Formulation Development Outsourcing (Pre-formulation Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Formulation Development Outsourcing (Pre-formulation Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Formulation Development Outsourcing (Formulation Optimization) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Formulation Development Outsourcing (Formulation Optimization) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Formulation Development Outsourcing (Injectable) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Formulation Development Outsourcing (Injectable) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Formulation Development Outsourcing (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Formulation Development Outsourcing (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Formulation Development Outsourcing (Topical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Formulation Development Outsourcing (Topical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Formulation Development Outsourcing (Other Dosage Forms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Formulation Development Outsourcing (Other Dosage Forms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Formulation Development Outsourcing (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Formulation Development Outsourcing (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Formulation Development Outsourcing (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Formulation Development Outsourcing (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Formulation Development Outsourcing (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Formulation Development Outsourcing (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Formulation Development Outsourcing (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Formulation Development Outsourcing (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Formulation Development Outsourcing (Respiratory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Formulation Development Outsourcing (Respiratory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Formulation Development Outsourcing (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Formulation Development Outsourcing (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Formulation Development Outsourcing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Formulation Development Outsourcing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Formulation Development Outsourcing (Pharmaceutical and Biopharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Formulation Development Outsourcing (Government and Academic Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: North America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: North America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: United States: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: United States: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Canada: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Canada: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: Asia-Pacific: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: Asia-Pacific: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: China: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: China: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Japan: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Japan: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: India: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: India: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: South Korea: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: South Korea: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Australia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Australia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Indonesia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Indonesia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Europe: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Europe: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Germany: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Germany: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: France: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: France: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: United Kingdom: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: United Kingdom: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Italy: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Italy: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Spain: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Spain: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Russia: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Russia: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Latin America: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Latin America: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Brazil: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Brazil: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Mexico: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Mexico: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Others: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Others: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Middle East and Africa: Formulation Development Outsourcing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Middle East and Africa: Formulation Development Outsourcing Market: Breakup by Country (in %), 2022
  • Figure 87: Middle East and Africa: Formulation Development Outsourcing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Formulation Development Outsourcing Industry: SWOT Analysis
  • Figure 89: Global: Formulation Development Outsourcing Industry: Value Chain Analysis
  • Figure 90: Global: Formulation Development Outsourcing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Formulation Development Outsourcing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Formulation Development Outsourcing Market Forecast: Breakup by Service (in Million US$), 2023-2028
  • Table 3: Global: Formulation Development Outsourcing Market Forecast: Breakup by Dosage Form (in Million US$), 2023-2028
  • Table 4: Global: Formulation Development Outsourcing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Formulation Development Outsourcing Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Formulation Development Outsourcing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Formulation Development Outsourcing Market: Competitive Structure
  • Table 8: Global: Formulation Development Outsourcing Market: Key Players